My understanding was the $957M or let's say $1B for market size, means revenue. The Gilder report on the Weebit website is written that way.
Weebit-SEP-22_Gilder-Report-Flash-Flood-Coming-Non-volatile-Memory-Technology-RRAM.pdf (weebit-nano.com)
Right-hand column, page 5 of the PDF:
"The current size of the ReRAM market may seem insignificant to the big memory players like Samsung, Micron and SK Hynix, but the projected growth of the “flash flood” looms as a transformative opportunity. Even assuming Weebit Nano is able to command only one-third of the total ReRAM market by 2030, it would have a revenue-generation potential more than $300 million, equivalent to the company’s stock market capitalization in U.S. dollars today."
Clearly this report assumes $2.9B Embedded NVM, and $1B for ReRAM, and $300M for WBT are Revenue figures, not a market size where 1.5% is then applied. So the confusion is in the term "market size" being used interchangeably with "market revenue".
Which is it?
- Forums
- ASX - By Stock
- WBT
- Running discussion on SP
WBT
weebit nano ltd
Add to My Watchlist
0.00%
!
$1.82

Running discussion on SP, page-2547
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.82 |
Change
0.000(0.00%) |
Mkt cap ! $377.2M |
Open | High | Low | Value | Volume |
$1.83 | $1.83 | $1.78 | $260.6K | 144.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 2601 | $1.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.82 | 1272 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 2147 | 1.810 |
10 | 5221 | 1.805 |
5 | 3037 | 1.800 |
6 | 6669 | 1.795 |
7 | 18730 | 1.790 |
Price($) | Vol. | No. |
---|---|---|
1.815 | 2349 | 8 |
1.820 | 3560 | 6 |
1.825 | 7360 | 7 |
1.830 | 25912 | 6 |
1.835 | 3649 | 6 |
Last trade - 12.11pm 07/07/2025 (20 minute delay) ? |
Featured News
WBT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online